The University of Nottingham, with funding worth £2.2m, is to carry out a study of the most common cause of Bovine Mastitis in the UK - Streptococcus uberis (S. uberis). If researchers can identify which parts of the bacteria enable the infection their results could lead to the production of an effective vaccine.
James Leigh, Professor of Molecular Bacteriology, who has recently joined the School of Veterinary Medicine and Science, said: "We hope to uncover bacterial antigens of potential use in vaccines aimed at preventing bovine mastitis and provide a detailed understanding of how animals can fight off the disease."
S. uberis is responsible for a significant proportion of clinical mastitis worldwide - but unlike many other bacteria that cause the disease, S. uberis is also in the environment - it is found in pasture and bedding and can even colonise the cow at other body sites with no ill effect - so it is difficult to see how it can be controlled by changes to animal husbandry and milking-time hygiene.
With funding from the Biotechnology and Biological Sciences Research Council (BBSRC) the School of Veterinary Medicine and Science has established research laboratories at the Institute for Animal Health (IAH). The project is being conducted in collaboration with Dr Tracey Coffey's Bovine Genomics group based at IAH and other groups at the Royal Veterinary College, the US Department of Agriculture in the UK and the University of Oxford.
Professor Leigh said: "We will use state-of-the-art molecular technology to determine the differences between strains of S. uberis that can and cannot cause disease. Proteins that are only present in the disease causing strains hold the key to determining which components are essential for infection. We will show which of these proteins are most likely to make an effective vaccine by producing strains of S. uberis which lack the ability to produce each of these proteins; if a strain lacking a particular protein is less able to cause disease then this protein is important for the disease process and becomes a candidate for vaccine development."
The team also want to identify any parts of the immune response in the dairy cow which can be altered to prevent the disease - this information could subsequently be used to develop drugs that interfere with the chemical messages that lead to inflammation and therefore reduce the level of disease.
Used to treat calf diarrhoea, Locatim is an orally administered product, indicated for the reduction of mortality caused by enterotoxicosis associated with E. coli F5 (K99).
The product is made from the colostrum of high health status cows hyperimmunised against Rotavirus, Coronavirus and E.coli.
Locatim is designed to work alongside the dam’s colostrum, enhancing protection against gastro-intestinal infection and helping to sustain calf health in the critical neo-natal period.
For optimal effect, Forte says Locatim should be given within 4 hours of birth, but can be used up to 12 hours post-natally.
Forte says Locatim is not designed to replace anti-scour vaccination programmes, rather to act as an extremely useful adjunct in cases where the response to vaccines has been less than ideal.
The company says Locatim is also extremely useful in managing outbreaks of scour in unvaccinated herds by protecting those calves born before a new vaccination programme can take effect.
Locatim is available from all UK veterinary wholesalers.
For more information, contact your Forte Territory Manager or enquiries@fortehealthcare.com.
Origin (previously known as Westpoint) has announced that FarmVets SouthWest has joined the group, giving further geographical coverage to its veterinary practice network.
FarmVets SouthWest has practices at Ilminster and North Petherton in Somerset and Honiton in Devon.
Eoghan McAlonan, a director of the practice, said: "We are delighted to be joining Origin. The Origin group delivers the highest standards in veterinary services to UK agriculture, and we will bring our farmer friendly services to further enhance the groups activities".
In turn Origin says it plans to bring the wide benefits of group membership, including lab services, dairy consultancy and paraprofessional services, to further enhance the high level of service the vet team at Farmvets SouthWest provide to producers in Somerset and Devon.
Jon Mouncey, Managing Director of Westpoint Farmvets, said: "Working alongside our other Origin practices in the South West region, we can now offer all livestock producers our advanced services, ensuring their stock receive the very best in veterinary care. Our group offers a unique approach to integrated veterinary services and by applying the latest technology and research we ensure that animal health and welfare is optimised, delivering real value for our clients in a challenging agricultural climate."
With the end of the vector-free period and the threat of more cases of bluetongue, organisations from across all elements of the livestock sector have come together to launch a Joint campaign Against Bluetongue (JAB), with the strapline ‘don’t hesitate, vaccinate’.
The organisations involved, which represent livestock farmers, livestock markets and meat and dairy processing as well as the veterinary profession, all fully support the joint industry/Defra vaccination plan for bluetongue and are committed to working together on the campaign to achieve the mass vaccination of bluetongue susceptible animals, including goats and camelids.
JAB is now embarking on a major campaign to urge all farmers with susceptible livestock to vaccinate their animals as soon as vaccine is available and the BVA, along with our relevant specialist divisions, is committed to ensuring that vets have all the information in advance so that they are in a position to deal with their clients’ questions.
According to BVA President Nick Blayney: "Colleagues should be aware and look out for meetings being organised around the country, courtesy of the VLA and others, and led by vets where they can learn the latest information. The BVA website also carries useful and up-to-date information and links (http://www.bva.co.uk/policy/bluetongue_jab.asp). Practices are seen as the cornerstone of vaccine delivery, proper usage and monitoring for efficacy and BVA would encourage them to offer their clients the ability to register an interest in vaccine supply in advance of its arrival. Such a forward order book will speed up the delivery of the vaccine once it is available."
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."
The existing MSD Animal Health Connect Bursary and Ruminant Research Bursary have been combined into the new MSD Animal Health Research Bursary which is designed to support the future of the veterinary profession through research.
The student arm of the new Research Bursary will award £1,000 to the five best research project applications received from veterinary students across all UK veterinary schools, with an opportunity for an additional £1,000 top prize and £500 runner-up prize.
The veterinary surgeon arm of the Research Bursary will offer three awards, consisting of two ruminant awards and one companion animal award, of up to £4,000 each. The veterinary practitioner proposals will be judged by University academics to ensure independent assessment.
Michelle Townley, Veterinary Advisor at MSD Animal Health said: "Our existing Research Bursaries are well known amongst students and practitioners, having run for over 25 years for the student bursary and 6 years for the ruminant bursary. To increase our support for the veterinary profession through research we have decided to combine our Research Bursaries and add some new categories to help appeal to as wide an audience as possible. This way we can offer a broader level of support for both existing companion animal and ruminant practitioners and our veterinary surgeons of the future. We aim to engage as many people as possible so the MSD Animal Health Research Bursary will be supported by a new website page and social media package to encourage as much interest from students and practitioners as possible."
Student bursary applications are now invited, with a deadline for entries of Friday 26th May 2017. Veterinary practitioners will be invited to apply in September 2017.
For further details go to the MSD Animal Health Research Bursary website at www.msd-animal-health.co.uk/researchbursary.aspx.
Bayer Animal Health has announced the launch of Ceffect (cefquinome), for the treatment of bacterial infections in cattle and pigs caused by Gram-positive and Gram-negative micro-organisms sensitive to cefquinome.
Ceffect is available as a 25mg/ml suspension for injection of cattle and pigs, and as Ceffect LC, a 75mg intramammary ointment for lactating cows.
In cattle, Ceffect 25mg/ml suspension for injection is licensed for the treatment of respiratory disease caused by Pasteurella multocida and Mannheimia haemolytica, and also for the treatment of digital dermatitis, infectious bulbar necrosis, acute interdigital necrobacillosis, and acute E.coli mastitis with signs of systemic involvement.
In calves, Ceffect 25mg/ml suspension for injection is licensed for the treatment of E.coli septicaemia
In pigs, Ceffect 25mg/ml suspension for injection targets cefquinome-sensitive organisms including Pasteurella multocida, Haemophilus parasuis, Actinobacillus pleuropneumoniae and Streptococcus suis which can cause bacterial infections of the lungs and respiratory tract. It is also licensed for the treatment of Mastitis-Metritis-Agalactia syndrome (MMA) with involvement of E.coli, Staphylococcus spp., Streptococcus spp. and other cefquinome-sensitive organisms.
In piglets, Ceffect 25mg/ml suspension is licensed for the reduction of mortality in cases of meningitis caused by Streptococcus suis. For the treatment of arthritis caused by Streptococcus spp., E. coli and other cefquinome-sensitive organisms, and epidermitis (mild or moderate lesions) caused by Staphylococcus hyicus.
Ceffect LC, 75mg intramammary ointment for lactating cows also contains cefquinome and comes in individual 8g prefilled syringes for treatment of clinical mastitis caused by Streptococcus uberis, Streptococcus dysgalactiae, Staphylococcus aureus and E. coli, in lactating dairy cows.
For further product information, visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
Esme grew up in Birmingham and spent much time in her teenage years working at the Domestic Fowl Trust caring for a range of rare breed poultry.
She said: "I didn’t grow up on a farm, but worked with chickens as a teenager and I love them to bits.
"They are amazing animals and I’ve wanted to work with them ever since.”
After graduating at the University of Liverpool, she spent two years with Howells Veterinary Services where she worked with clients to foster improved performance under an increasing drive for sustainability.
Now with St David’s Poultry Team in Yorkshire, she helps broiler clients in reducing viral challenge on farm to increase immunocompetence and so decrease susceptibility to other challenges.
She has also just become the youngest vet ever to achieve a Certificate in Advanced Veterinary Practice (Poultry), which she gained at the University of Liverpool.
The Young Farm Vet of the Year Awards is sponsored by Zoetis.
CEVA Animal Health is supplying a free, multi-dose injector gun with a self-sterilising needle system, with the purchase of bulk quantities of its luteolytic and uterotonic prostaglandin Enzaprost, while stocks last.
According to the company, the use of naturally occurring prostaglandins such as Enzaprost play an important role in any fertility management programme, working by causing lysis of the corpus luteum. Enzaprost can be used to control the timing of oestrus and synchronisation for AI; for the treatment of sub-oestrus or silent heat; for the induction of abortion up to day 120; for the induction of parturition and as an aid in the treatment of chronic metritis or pyometra where there is a functional or persistent corpus luteum. Natural prostaglandins also have a uterotonic effect which may be useful in the treatment of 'dirty' cows.
CEVA says any multi-cow injection programme has its risks, and that experience has shown that one in 250,000 injections can result in clostridial infection. Invariably this occurs in sequential animals, with the causal agent found in the bottle as a result of inadvertent needle contamination. Multi-dose syringes reduce the number of needle punctures into a bottle and the Sterimatic caps clean the needle before and after each injection helping to minimise the risk of infection. One Sterimatic cap can be used for 72 hours or up to 100 injections. The covered needle also provides increased safety for the operator, resulting in fewer needle stick and scratch injuries.
To find out how you can receive a free multi-dose injector with the Sterimatic needle protector system, which includes five caps and one needle protector, please contact your local CEVA territory manager
For copies of CEVA's fertility newsletters or for further product information please contact the large animal sales team or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
The new 'SMART goals tool' is an addition to the charity's Farm Vet Champions programme, which supports veterinary teams with knowledge and resources to ensure antimicrobials are used responsibly.
To support the take-up of the new SMART goals tool, RCVS Knowledge will be running a free webinar on Zoom at 12:30pm on Tuesday 17th May (register here).
Fiona Lovatt, Farm Vet Champions Clinical Lead, said: “It is such a critical time to ensure we are using antimicrobials responsibly so that they will work when patients really need them.
"We all have a responsibility to fight antimicrobial resistance. The good news is there is a lot we can do – one of those things is getting involved with Farm Vet Champions, enhancing our skills and adapting our practice.
“I am so excited to see the launch of our SMART goal tool. It is both engaging and simple to use, and I expect it will encourage practice teams to motivate each other to track their progress in their stewardship activities.
Fraser Broadfoot, Head of Antibiotic Use and Stewardship Team at Veterinary Medicines Directorate, said: “We are really supportive of this important initiative.
"In the UK we have seen a 52% reduction in antibiotic use for food producing animals since 2014, and this has been driven by vets and farmers working together to reduce unnecessary use of antibiotics and with a strong focus on disease prevention.
"However, as highlighted in the RUMA sector targets, there are still areas where improvements can be made and where antibiotic use data is lacking.
"This SMART goals tool therefore provides an easy-to-use and practical resource that is designed to help and motivate vets and practice teams to set, monitor and accomplish goals and build on the tremendous progress that they have already achieved.
"This will not only help the livestock sectors to achieve their targets, but will result in improvements in animal health and, by reducing the burden of resistant bacteria, have public health benefits too.”
Dr Johanna Fink-Gremmels – Professor of Veterinary Pharmacology and Toxicology at Utrecht University – has warned that UK cattle producers need to plan for an on-going struggle with feed-borne mycotoxins, and says vets need to help farmers understand and mitigate the negative impact on animal health.
Speaking to cattle vets at a CPD meeting organised by Alltech, she said: "When you see a general inflammatory response, such as elevated somatic cell count, mycotoxicosis should always be on your radar. The mycotoxin threat to cattle is increasing in the UK, yet it is often the most neglected causative issue on any list of pathogenic suspects."
Johanna explained that natural toxins produced by diverse fungal species are proliferating worldwide, partly as a result of global climate change, but also because of changing agronomic practices in developed countries.
"Total mixed rations often now contain more than one fungal species, contributing to a complex mycotoxin picture and unresolved health issues in a herd as a result. Cow signals such as reduced feed intake, reproductive disorders, laminitis, mastitis, impaired liver function, a poor response to vaccination programmes and even increased susceptibility to bacterial and viral diseases can all be attributed to ingesting mycotoxin contaminated feed."
Johanna says the biggest challenge for UK dairy farmers is now multiple mycotoxin contamination of grass and maize silage.
"Cattle health problems with feeding obviously mouldy silage are relatively well understood. But new harder to detect fusarium toxins – such as, for example, Enniatins and Beauvericin contaminating cereal grains – are also now being found in pasture grass in Northern Europe. These will also adversely affect the efficiency and function of the rumen.
"The rumen determines the health and productivity of the cow. When rumen bacteria are suffering the liver does not function correctly initiating a cascade of adverse events; and often a generalised inflammatory response is triggered, which leads to a loss of production."
Johanna added that in the future farmers will need select feed crop plants that are more resistant to fungal invasion and will also have to re-adjust tillage methods to reduce mould contamination. "However, we know that this alone will not stamp out mycotoxin contamination without creating a biological vacuum that will be filled with other micro-organisms.
"Consequently, it will be essential to continue to apply strategies such as rigorous on-farm risk assessment and the use of appropriate in-feed mycotoxin-sequestration agents (binders) to prevent the production-limiting and adverse health effects in our farmed livestock."
The award, introduced in 2020 and supported by animal health company Krka UK, recognises an exceptional farm vet who has been working in the dairy industry for three to five years and who has contributed significantly to the health and wellbeing of herds under their care.
The winner of the first award, in 2021, was Rob Hall from LLM Farm Vets in Shropshire. He said: "The sustainability of the dairy industry will remain in the spotlight for decades to come with young vets in a great position to work with dairy farmers of the future to improve the efficiency of their herds. This can be achieved, for instance, by improving nutrition, genetics and housing; by helping farmers to reduce antibiotics or wormers; and by reducing the detrimental effects of disease.”
He added: “As vets start their post-university careers, they face a steep learning curve. Dairy vets, in particular, have a huge arsenal of practical skills to hone, as well as trying to forge relationships with farmers and colleagues. It can be tricky to strike the right balance, while finding time to pursue their own interests to keep work interesting. I’ve been lucky at LLM to have had the opportunity to work with a great team and engaged farmers. This has enabled me to pick up the basics, as well as being able to delve deeper into the aspects of farming which interest me most. I’m extremely grateful to The Cream Awards for recognising this and to KRKA for its support of the Young Dairy Vet Award.”
Charlotte Read (pictured right), Krka Key Account Manager – Farm, added: “Krka is proud to support the recognition of rising stars within the dairy veterinary profession and hope that their achievements will inspire many of the next generation of veterinary surgeons to embrace the rewarding life of the farm vet.”
Full details of all of the CREAM Awards and the nomination process is available at: https://creamawards.uk
Sedaxylan 20 mg/ml contains the short acting alpha-2 agonist xylazine and is licensed for I/V administration.
It is also licensed for I/M administration in cattle; it has zero milk withdrawal and short one day meat withdrawal and sedation occurs in cattle within two minutes I/V and five to 10 minutes I/M.
Sedaxylan 20 mg/ml joins Dechra’s Nerfasin vet 100 mg/ml solution in the company’s anaesthesia and sedation range. Nerfasin vet also contains xylazine and is licensed for I/V administration for sedation and premedication prior to general anaesthesia in horses and cattle.
Alana McGlade, national sales manager at Dechra, said: “Dechra offers a comprehensive range of anaesthesia and sedation products allowing vets to customise protocols to the individual animal.
"Sedaxylan 20mg/ml and Nerfasin vet 100 mg/ml solution provide vets with flexible and convenient dosing options.”
Both Sedaxylan 20 mg/ml and Nerfasin vet 100 mg/ml are available in 25ml vials.
For more information, talk to your Dechra territory sales manager.
www.dechra.co.uk.
Intervet/Schering-Plough has announced that the license for Leptavoid-H has been improved allowing concurrent use with Bovilis BVD.
Intervet/Schering Plough says that given both vaccines are typically administered in the busy pre-turnout period, this will ease on-farm workload and should help to ensure that all primary courses or boosters take place sufficiently in advance of the period of risk.
Each vaccine is to be given by separate routes and sites, to animals of 8 months or older. The concurrent use in cattle may result in fewer animal interventions, less stress and better welfare.
The studies, undertaken by Intervet/Schering Plough's R&D division in the UK, focussed on both the safety and efficacy aspects of the concurrent administration of Leptavoid-H with Bovilis BVD. The company says no systemic adverse events occurred, there was no effect on the outcome of pregnancy or milk yields and the efficacy in cattle was not compromised.
Leptavoid-H is licensed to reduce the shedding of Leptospira interrogans serovar hardjo in urine. Leptavoid-H is the only Leptospirosis vaccine licensed to improve herd fertility when Leptospira hardjo is the cause of herd infertility, and the only vaccine proven to protect stock against both strains in the UK.
Guidelines on the examination of rams for breeding have now been officially updated, thanks to the pooled expertise of delegates at a recent Sheep Fertility Workshop, sponsored by Ceva Animal Health, the Sheep Veterinary Society and EBLEX-AHDB.The previous Sheep Veterinary Society guidelines on the examination of rams for breeding were drawn up in 2007. However, the society says that to date, there has been considerable variation in the practice of ram fertility testing amongst sheep vets across the country.
The Sheep Fertility Workshop, which was held in Edinburgh in June 1014, brought together veterinary experts and scientists to discuss the provision of a comprehensive, evidence-based, best practice protocol, with clear recommendations for practitioners on the assessment of rams.Dr Fiona Lovatt, senior vice president of the Sheep Veterinary Society and director of Flock Health Ltd, who coordinated the workshop, said: "The outcome of some active debating was the recognition that various elements of the guidelines needed to be updated in line with currently recognised best practice. One thing that is really essential is that the practising vet is clear as to the reason for the ram PBE and carefully considers how to communicate the findings and their limitations to the ram's owner."
The updated guidelines cover three levels of ram pre-breeding examinations (PBE):
Carol Atkinson, Ceva's reprodAction range marketing manager, said: "We are proud to have supported the workshop, the outcome of which has been some valuable modifications to the guidelines. We now have a robust, practical benchmarking system in place to help ensure consistency of ram fertility and flock health and development."
The workshop was funded by the Sheep Veterinary Society, Ceva Animal Health and EBLEX-AHDB, with contributions in kind from Innovis, Zoetis and Novartis Animal Health.
The guidelines are available to all members of the Sheep Veterinary Society and can be downloaded from www.sheepvetsoc.org.uk, together with two further forms that are available following appropriate training: SVS Ram PBE data collection and SVS Ram certificate. The Sheep Veterinary Society will be holding a series of CPD days for practitioners in advance of next year's breeding season. Further details will be posted on the website shortly.
BovIntel is software which, alongside the company's Easi-Scan:Go bovine ultrasound scanner, automatically identifies and measures important features on ultrasound images in real time as a vet carries out a scan.
The software uses colour to highlight and label structures such as follicles and corpus luteums, displaying the measurements of these to the nearest millimetre.
The technology has been designed to make the fertility scanning process easier and more accurate, helping vets give more informed breeding advice.
The developers behind BovIntel say the information that it provides will improve pregnancy rates and therefore overall productivity of dairy herds.
Alan Picken, Imaging Innovation Director said: “Pregnancy rates are notoriously low in the US and across Europe with as few as one in three inseminations producing a pregnancy.
"This is costing the industry time and money.
“Diagnostics on ovarian health is only possible through ultrasound and veterinary assessment, but not all vets are offering this service to their clients.
"BovIntel makes this ultrasound information more accessible to vets, and vastly increases the value and efficacy of the advice they provide to clients.
“Essentially, it enables a vet to quickly and accurately assess the ovarian health of a cow, so they can advise on how to achieve conception at the earliest opportunity.
"Equally, it allows them to quickly establish if a cow is unlikely to get pregnant and prevent a wasted insemination.”
IMV Technologies says new technology also promises to reduce the fertility scanning training time of newly qualified vets, by helping them to quickly find the ovaries during a scan and giving them confidence in interpreting ultrasound images.
Aland added “New vets will be able to practice independently faster and need the support of senior vets for less time, both of which brings huge benefits to their confidence and professional development and to the productivity of the business.”
IMV says the technology will also be useful for universities and research organisations investigating dairy cow reproductive health.
BovIntel is a software addition to IMV’s Go:Scan app.
It can be used via the viewing app, but also with BUG headsets, augmenting in colour for VGA and colour OLED. For users with mono BUG:Go headsets it will appear as grayscale on the headset screen, but in colour on the viewing app.
There's a 30-day free trial of the software for vets using the Go:Scan app, after which there is a choice of a subscription or pay-as-you-scan.
Norbrook Laboratories has launched Cefimam DC intramammary ointment, a new dry cow preparation containing the 4th generation cephalosporin, cefquinome.
The company has also released a Polish language version of its Best Practice Guide for On-Farm Mastitis Control, in response to demand from producers with non-English speaking farm-hands.
Norbrook vet Chris Geddes said: "I believe this is the first time that such a guide has been produced to cater for farm-hands of a different nationality working within the UK. Good mastitis management starts with good education; giving everyone on the farm the same opportunity for learning the best techniques for prevention means that we help minimise incidences of mastitis, which costs the dairy industry millions of pounds in lost revenue every year.
"This prevention includes a thorough and consistent approach to dry cow management. The early drying off period is often a risky time, when pre-existing subclinical infections can bed-in. The cow is also at increased risk of gaining new infections due to lack of udder hygiene procedures that would normally occur at milking, and weakened immunity as she approaches calving. Our new cefquinome preparation is a valuable addition to have in the treatment armoury for dry cow management. It has broad-spectrum activity and high cellular penetration to help tackle hard-to-manage cases with the aim of returning to maximum productivity by the start of the milking season."
Cefimam DC will be available at all veterinary wholesalers in packs of 24x and 120x 8g intramammary tubes. Vets can obtain both English and Polish versions of the Best Practice Guide for On-Farm Mastitis Control from Territory Managers.
For further information or copies of the Best Practice Guide for On-Farm Mastitis Control in English or Polish, contact your Territory Manager or call Norbrook GB head office on 01536 741 147.
Grahame Gardner has introduced the M559, a classically styled tunic, stocked for the first time in bottle green.
The company says that although it has sold numerous ladies tunics in bottle green, this is the first time it has stocked a male tunic in the characteristic veterinary colour.
The M559 incorporates side fastening with the option of contrasting epaulettes, alongside practical pockets and side slits.
Simon Ward, Sales Director said: "We are delighted to introduce this new garment to the veterinary market. We are continually reviewing our range in response to customer comments, and felt it was time we stocked a bottle green option, specifically for male members of the veterinary team."
Stocked in sizes from 34" to 50" (chest), the M559 is just one of several new styles introduced in Grahame Gardner's latest brochure. The company is also launching a new men's scrub tunic. The SS3295 has a v style neck, complemented by the v-detail on the sleeves, and contrasting trim available on the neck, sleeve and pocket. Also stocked in bottle green, the company says this tunic is aimed at veterinary professionals who prefer a more relaxed approach to uniforms.
To explore Grahame Gardner's collection please take a look at http://www.grahamegardner.co.uk/, or call 0116 255 6326 to order a copy of their new brochure.
From today, porcine epidemic diarrhoea (PED) is a notifiable disease in England; veterinary surgeons and pig-keepers are now legally required to inform the Animal and Plant Health Agency of any suspicion of the disease.
If a test for PED proves positive, the Government will inform AHDB Pork, so that tracing can be carried out and improved biosecurity measures put in place.
The new measure has been introduced following co-operation between Defra APHA, AHDB Pork, the NPA and other industry bodies. Although PED is now classified as notifiable, there will be no statutory movement controls, no compulsory slaughter and no blocks on exports.
Under the new legislation in England, APHA will be legally permitted to inform AHDB Pork - which is the agreed 'appropriate organisation' - in confidence of suspect and confirmed cases. AHDB Pork will then provide biosecurity guidance to the pig unit concerned. It will also carry out tracing and alert at-risk contacts as necessary.
The aim will be to prevent spread of PED and to eliminate the disease from the pig unit. There will be no requirement to slaughter affected animals.
PED has been made lightweight notifiable following an informal consultation process with the pig industry. NPA and others called for the measure so that any outbreak can be identified as quickly as possible, spread can be prevented, and the disease can then be eliminated from the unit concerned.
AHDB Pork Chairman Meryl Ward said: "This initiative is a significant step change in partnership working between industry, Defra and the APHA to build England’s resilience to disease.
"PED is a potentially serious disease and emerging threat to our English pig industry. A unique industry led collaboration with Government led to the development of the PEDv Contingency plan to ‘identify, contain and eliminate’.
"The regulatory change to notifiable status is a critical part of the plan and will assist in early identification of affected premises, allowing more time to take effective actions to minimise the impact on the industry and therefore increasing the opportunity to eliminate the disease.
"Working together to share resource, knowledge and build vital expertise, the partnership has also developed a series of standard operating procedures, bio- security guidance as well as raising awareness across industry of the potential threat.
PED remains a significant threat to British pig-keepers. According to AHDB, outbreaks of high-impact strains caused up to 100% mortality in young pigs in the United States, knocking out around 10% of pig production in 2013-2014. The disease has since spread to Ukraine. Even with milder European Union strains, piglet mortality as high as 70% has been reported.
The Scottish Government is currently consulting on making PED similarly lightweight notifiable in Scotland.
The BVA and the Pig Veterinary Society (PVS) have welcomed the announcement. John Blackwell, Senior Vice President of the British Veterinary Association, said: "From today pig-keepers will be required to contact APHA if they have any suspicion of PED in their livestock - this is a step in the right direction and a result of joined up working between the industry, the veterinary profession and policy makers. PED is a devastating disease and we hope these measures will be sufficient to protect animals and pig-keepers in England from future outbreaks. We are encouraged by current proposals to make PED notifiable in Scotland and are keen to see similar measures in place across the rest of the UK."
Dr Mandy Nevel, President of the Pig Veterinary Society, said: "The Pig Veterinary Society was actively involved in the decision to make PED notifiable in England and we fully support the decision. Whilst we hope PED does not come into England, the legislation will facilitate rapid diagnosis, control and eradication in the event of a case occurring. We urge the rest of the UK to take similar action."
Photo: Ben Salter: Pig in a bucket
Emma, who graduated from the RVC in 2016, first spent five years working for the Poultry Health Services team in North Yorkshire, before moving to Avara to gain on-farm experience as an area manager.
She then rejoined the PHS Sheriff Hutton practice as the veterinary lead for the North East in 2022, opting to return to clinical work where her main interest is in turkeys focusing on gut health.
Emma has a post-graduate diploma in population health, statistics and epidemiology, and sits on both the APHA Avian Expert Group and the British Veterinary Poultry Association committee.
The judges were impressed with Emma's commitment to poultry as well as taking on several other roles on committees supporting the industry.
John Kenyon, Veterinary Manager at award sponsor Zoetis, said: “The poultry industry is looking to attract more vets to specialise in this sector and Emma is a great role model.
“The profession plays an important part in maintaining the high health and welfare standards of the UK industry and the award is a great way to promote career opportunities for young vets.
"Zoetis has sponsored this award since the introduction of the Young Farm Vet category in 2020 and we are proud to see the success past winners have achieved.”
Other finalists included Esme Chapman of Howells Veterinary Services, and Katerina Theakou of Crowshall Veterinary Services.
Fynadyne had been removed from sale last year after the Veterinary Medicines Directorate suspended the sale of any medicinal products containing the excipient diethanolamine (DEA), following advice to the European Medicines Agency that it could pose a risk to human health.
Finadyne 50mg/ml Solution for Injection is indicated for the alleviation of acute inflammation and pain in both cattle and pigs. It is also indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders and colic in horses.
The reformulated product has a shelf life of three years and is now available from wholesalers in 50ml and 100ml vials.
For further information, contact your MSD Animal Health account manager.
The Veterinary Marketing Association has announced details of a new award for public relations, open to veterinary practices and companies.
The VMA says this award is to recognise the value that media and public relations can add to the marketing mix. It will be awarded to the company or veterinary practice that has delivered the most innovative PR campaign during 2011, as judged by a panel of industry professionals.
Organiser Claire Edmunds said: "The VMA Awards has become a coveted event for those involved in the animal health industry to showcase their marketing achievements. A range of categories has evolved since the awards began over 20 years ago, for marketing, creative communication and new media campaigns. However, we felt that an award for PR was required to complete the marketing mix".
Jane Manning from award sponsor Splash Marketing & Communications said: "We felt it was time to give the opportunity for those involved in PR to obtain the recognition they deserve alongside their creative colleagues.
"An effective PR campaign can be a highly influential marketing tool, so it's great news that the VMA has added this new award category. We hope that companies and agencies serving the animal health sector will embrace this new opportunity to showcase their creativity and hard work".
The award is for the most innovative PR initiative published during the year. This can be a single 'one-off' event or article, or a sustained campaign over a given period. The winner and two highly commended entries will be awarded at the VMA Awards on Friday 9th March 2012 at Shakespeare's UnderGlobe Theatre, London.
Further information on the awards and ticket application forms are available at the VMA's website - http://www.vma.org.uk/ or by calling 0844 561 6157. The deadline for entries is Friday 27th January 2012.
Merial has published figures which show that gutworm is seriously affecting dairy cow fertility in up to 80% of UK dairy herds1, in order to raise awareness of the damaging impact of Ostertagia ostertagi.
Sioned Timothy, veterinary adviser for Merial said: “The reduction in milk production from a gutworm infection is well documented2. Both animal health advisers (Suitably Qualified Persons – SQPs) and vets recognise the threat such infections cause. However, since cows often show no outward signs of disease, even in the face of a massive challenge, dairy farmers could unwittingly suffer heavy losses in milk yield, reduced fertility and increased heifer rearing costs at a time when they can least afford it.”
Merial points out that the extent of a herd’s gutworm exposure can be easily and simply assessed from a sample taken from the bulk milk tank – using the MOO Test. This test determines the amount of antibody to Osteragia ostertagi present in a sample, giving an assessment of the level of herd gutworm challenge.
The metabolic demands placed on cows during the post-calving period can lead to a negative energy balance, when energy gained from feed intake is less than that used for milk production. This natural ‘energy gap’ leads to weight loss; a parasite burden can make matters worse.
Sioned advises taking action to reduce the effect of this post-calving energy gap to maintain productivity levels. She said: “Management of cows in the weeks following calving should focus on maximising dry matter intake to correct the energy imbalance as quickly as possible. Studies have shown that cows treated for gutworm have improved appetites, and graze for up to an hour longer than untreated cows3. Grass is the cheapest form of nutrition so it makes sense to make the most of it.”
Merial also points towards studies which have shown that effective parasite control may have a beneficial effect4,5. Reduced body condition scores caused by the energy gap after calving may impact on reproductive parameters. In one study, cows treated for gutworm were back in calf 13 days sooner than untreated animals4.
Sioned said: "This has obvious implications for productivity. We need to look at employing a range of practical measures to ensure cows are as productive and efficient as possible, and this includes targeted worming where required.”
According to the company, effective parasite management of the replacement heifer during the rearing period is key to her future performance and productivity. Achieving breed-appropriate target weights throughout the rearing period is a crucial component of heifer rearing. The onset of puberty and the start of breeding are more closely linked to weight, body size and condition score than age. It is therefore critical to ensure that heifers reach approximately 60% of mature weight by 14 months of age in order to achieve a 24 month average age at calving.
Sioned said: “Losses in potential liveweight gain due to poor parasite control during a heifer’s first grazing season will not be recouped during the second year at grass6. She won’t catch up, and this will impact on her ability to meet important milestones.”
Getting heifers in-calf at the optimal time will help to reduce breeding costs and maximises the potential productive life of the animal. Heifers treated for gutworm have been shown to have a 20% higher conception rate at first service than untreated cattle2.
Merial says there is also evidence that parasite burdens exert physiological effects that directly impact on the parameters influencing performance and profitability of heifers, and increased mammary development and earlier onset of puberty have been observed in strategically wormed heifers in comparison to those left untreated7,8.
Sioned said: “Effective worming will mitigate the effect of parasites on fertility levels in growing cattle4, while still allowing them to build the necessary immunity required to prevent clinical disease in adulthood.”
References